- Life sciences investment company NetScientific said it had invested further $1 million into its lifesciences' portfolio company, EpiBone.

EpiBone is a regenerative medicine company focused on bone and cartilage reconstruction based in the US.

'The funding will take EpiBone through to a scale-up round expected in late 2022, and enable the company to accelerate development of its pipeline,' the company said.

The investment amount was part of an overall $11 million close alongside other investors.

Story provided by